Evidence map›Paper›PMID 31757835›Full record

ArticleScience immunology2019

A divergent transcriptional landscape underpins the development and functional branching of MAIT cells.

H-F Koay, S Su, D Amann-Zalcenstein, S R Daley, I Comerford, L Miosge, C E Whyte, I E Konstantinov, Y d'Udekem, T Baldwin and 21 more

Open access · greenAbstract read
In one paragraph

Article in Science immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 1 synthesis or guideline pooled it, 119 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Metabolic control of innate-like T cells.Nature reviews. Immunology · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. MAIT cells: Conserved watchers on the wall.The Journal of experimental medicine · 2025
    Review
  18. Review
  19. Article
  20. Review

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 8 institutions in 1 country.

H-F KoayDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria 3000, Australia.ORCID 0000-0002-3236-9609
S SuEpigenetics and Development Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia.
D Amann-ZalcensteinSingle Cell Open Research Endeavour (SCORE), Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia.ORCID 0000-0003-4928-1846
S R DaleyDepartment of Immunology and Infectious Disease, John Curtin School of Medical Research, Australian National University, Canberra, Australia.ORCID 0000-0002-5870-644X
I ComerfordDepartment of Molecular and Biomedical Science, University of Adelaide, Adelaide, South Australia 5005, Australia.ORCID 0000-0001-8753-4774
L MiosgeDepartment of Immunology and Infectious Disease, John Curtin School of Medical Research, Australian National University, Canberra, Australia.
C E WhyteDepartment of Molecular and Biomedical Science, University of Adelaide, Adelaide, South Australia 5005, Australia.ORCID 0000-0001-6556-6855
I E KonstantinovRoyal Children's Hospital, Flemington Road, Parkville, Victoria 3052, Australia.
Y d'UdekemRoyal Children's Hospital, Flemington Road, Parkville, Victoria 3052, Australia.
T BaldwinSingle Cell Open Research Endeavour (SCORE), Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia.
P F HickeySingle Cell Open Research Endeavour (SCORE), Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia.ORCID 0000-0002-8153-6258
S P BerzinsDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria 3000, Australia.
J Y W MakDivision of Chemistry and Structural Biology, and Centre for Inflammation and Disease Research, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia.ORCID 0000-0002-8011-4539
Y SontaniDepartment of Immunology and Infectious Disease, John Curtin School of Medical Research, Australian National University, Canberra, Australia.ORCID 0000-0001-9553-5304
C M RootsDepartment of Immunology and Infectious Disease, John Curtin School of Medical Research, Australian National University, Canberra, Australia.
T SidwellDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria 3000, Australia.
A KalliesDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria 3000, Australia.
Z ChenDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria 3000, Australia.ORCID 0000-0003-1205-683X
S NüssingDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria 3000, Australia.ORCID 0000-0002-0685-3413
K KedzierskaDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria 3000, Australia.ORCID 0000-0001-6141-335X
L K MackayDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria 3000, Australia.ORCID 0000-0002-8496-6632
S R McCollDepartment of Molecular and Biomedical Science, University of Adelaide, Adelaide, South Australia 5005, Australia.ORCID 0000-0003-0949-4660
E K DeenickGarvan Institute of Medical Research, Sydney, Australia.ORCID 0000-0002-9271-0004
D P FairlieDivision of Chemistry and Structural Biology, and Centre for Inflammation and Disease Research, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia.ORCID 0000-0002-7856-8566
J McCluskeyDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria 3000, Australia.ORCID 0000-0002-8597-815X
C C GoodnowGarvan Institute of Medical Research, Sydney, Australia.ORCID 0000-0001-5296-6155
M E RitchieEpigenetics and Development Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia.
G T BelzImmunology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia.ORCID 0000-0002-9660-9587
S H NaikSingle Cell Open Research Endeavour (SCORE), Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia.ORCID 0000-0003-0299-3301
D G PellicciDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria 3000, Australia. godfrey@unimelb.edu.au dan.pellicci@mcri.edu.au.ORCID 0000-0001-5305-2398
D I GodfreyDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria 3000, Australia. godfrey@unimelb.edu.au dan.pellicci@mcri.edu.au.ORCID 0000-0002-3009-5472
The University of Melbourne · AUAustralian Research Council · AUAustralian National University · AUThe University of Adelaide · AUGarvan Institute of Medical Research · AURoyal Children's Hospital · AUWalter and Eliza Hall Institute of Medical Research · AUFederation University · AU

Funding

Systems Biology CoreU19AI100627 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI NOLAN, GARRY P · 2012 to 2021
$49.1M
NIAID NIH HHS U19 AI100627
6 · The paper itself

Abstract

MR1-restricted mucosal-associated invariant T (MAIT) cells play a unique role in the immune system. These cells develop intrathymically through a three-stage process, but the events that regulate this are largely unknown. Here, using bulk and single-cell RNA sequencing-based transcriptomic analysis in mice and humans, we studied the changing transcriptional landscape that accompanies transition through each stage. Many transcripts were sharply modulated during MAIT cell development, including SLAM (signaling lymphocytic activation molecule) family members, chemokine receptors, and transcription factors. We also demonstrate that stage 3 "mature" MAIT cells comprise distinct subpopulations including newly arrived transitional stage 3 cells, interferon-γ-producing MAIT1 cells and interleukin-17-producing MAIT17 cells. Moreover, the validity and importance of several transcripts detected in this study are directly demonstrated using specific mutant mice. For example, MAIT cell intrathymic maturation was found to be halted in SLAM-associated protein (SAP)-deficient and CXCR6-deficient mouse models, providing clear evidence for their role in modulating MAIT cell development. These data underpin a model that maps the changing transcriptional landscape and identifies key factors that regulate the process of MAIT cell differentiation, with many parallels between mice and humans.

Indexed as

AdultAnimalsCell DifferentiationHumansMiceMice, Inbred BALB CMice, Inbred C57BLMice, TransgenicMucosal-Associated Invariant T CellsSignaling Lymphocytic Activation Molecule FamilyTranscription, GeneticSignaling Lymphocytic Activation Molecule Family

Identifiers

PMID31757835
PMCPMC10627559
OpenAlexW2990813056

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.